As both protein structure and expression can be affected by genetic polymorphisms, a number of GWAS have investigated the association between XRCC3 polymorphisms and risk for cancers, including gliomas [33, 37, 39, 66–68]. Here, XRCC3 is linked to central nervous system cancer.